ANDA 77459, held by Hikma Pharmaceuticals. Losartan Potassium.
As of Nov 21, 2026, ANDA 77459 (Losartan Potassium), held by Hikma Pharmaceuticals, was first approved by FDA on Oct 6, 2010, with 10 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 6, 2010 | Original application | Approved | None posted |
| Losartan Potassium25MG · tablet;oral | Losartan Potassium | Discontinued |
| Losartan Potassium50MG · tablet;oral | Losartan Potassium | Discontinued |
| Losartan Potassium100MG · tablet;oral | Losartan Potassium | Discontinued |
| Jan 16, 2026 | Supplement 15Labeling · Standard review | Approved | None posted |
| Sep 16, 2022 | Supplement 14Labeling · Standard review | Approved | None posted |
| Sep 30, 2020 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jun 10, 2016 | Supplement 10Labeling · Standard review | Approved | None posted |
| Jun 13, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Sep 26, 2014 | Supplement 8Labeling · Standard review | Approved | None posted |
| Mar 19, 2013 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 19, 2012 | Supplement 6Labeling · Standard review | Approved | None posted |
| Feb 15, 2011 | Supplement 2Manufacturing | Approved | None posted |
| Nov 16, 2010 | Supplement 1Labeling | Approved | None posted |
| Oct 6, 2010 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters